Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Tencent Investment was among the participants in late-stage round for the online medical information and social networking service.

The intelligent chipmaker, which counts Microsoft, Samsung, BMW, Robert Bosch and Dell as investors, secured series E funding at a $2.77bn valuation.

The intelligent chipmaker, which traces its roots back to University of Bristol, has secured series E funding at a $2.77bn valuation.

Alibaba and SoftBank Vision Fund helped the online education services provider close a series E-plus round that hiked its overall funding to more than $2.9bn.

Long-time investor Tencent returned for a series E-plus round that lifted the big data technology provider's total funding to at least $956m.

The Sinopharm-backed antimicrobial drug developer received $107m in a Legend Capital-led round that took its overall funding to $255m.

Microsoft and Google participated in a round for the news aggregator's parent company, Verse Innovation, that will support its short-form video app.

Tencent co-led a series E1 round for the cancer drug development services provider, which counts China Electronics Corporation and Ping An as earlier investors.

SoftBank’s Vision Fund I and Latin America Fund returned for a round that hiked the online lending platform developer's valuation to $1.75bn.